Learn More
Apexbio Technology LLC Sulfaphenazole 526-08-9 1g

Supplier: Apexbio Technology LLC C41311000
Sulfaphenazole (CAS 526-08-9) is a small-molecule inhibitor targeting cytochrome P450 2C9 (CYP2C9) It is designed to selectively inhibit CYP2C9-mediated drug metabolism thereby informing metabolic pathway studies and investigation of drug-drug interactions Sulfaphenazole exerts its biological activity primarily through competitive inhibition of CYP2C9 In in vitro assays sulfaphenazole demonstrates potent inhibition with a reported Ki value of approximately 0 3 M for human CYP2C9 Based on these pharmacological properties sulfaphenazole holds research potential in evaluating CYP2C9-mediated metabolic processes and associated drug interactions
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.